OncoMatch/Clinical Trials/NCT02025023
Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study
Is NCT02025023 recruiting? Yes, currently enrolling (Jun 2026). This Phase 3 trial studies multiple treatments including 5-fluorouracil and Triamcinolone Acetonide for chalazion.
Treatment: 5-fluorouracil · Triamcinolone Acetonide · Triamcinolone Acetonide/5-fluorouracil mixture — Local injection of 5-fluorouracil into a chalazion (stye) is as effective as local injection of triamcinolone (steroid) and incision and curettage for treatment of chalazia.
Check if I qualifyEligibility summary
For patients with Chalazion.
This summary was generated by AI from the trial's official eligibility criteria and may contain errors. Always confirm with the study team before contacting a site.
US trial sites
- University of Washington Eye Institute at Harborview · Seattle, Washington
Showing up to 5 US sites.
See all sites on ClinicalTrials.gov →Frequently asked questions
Is NCT02025023 currently recruiting?
Yes, this trial is currently recruiting patients.
Could you qualify for this trial?
Enter your biomarker results to see how this trial's eligibility criteria match your specific cancer profile.
Check if I qualify